BPI-15086 is an orally active, effective, irreversible inhibitor selective for mutations, targeting both EGFR and the T790M resistance mutation tyrosine kinase. It can be utilized in the study of non-small cell lung cancer.
Molecular Weight:
593.08
CAS Number:
[1644502-33-9]
Formula:
C29H33ClN8O4
Target:
EGFR
T200004
* VAT and and shipping costs not included. Errors and price changes excepted
